Sunrest Lifescience Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Sunrest Lifescience Limited's yearly results (2023–2026), compared with companies in India. Tap ? on any ratio for what it means.
What stands out
- Profit Cash Ratio: Over the last 3 years, every ₹100 of reported profit came with ₹-188 of operating cash. Lower than 96% of companies in India.
- Cash Cushion Ratio: Debt, after subtracting cash, equals 81% of its market value (net debt). Lower than 91% of companies in India.
- Self-Funding Ratio: Over the last 3 years operating cash was negative while the company kept spending on investment (capex). Lower than 89% of companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹-188Over the last 3 years, every ₹100 of reported profit came with ₹-188 of operating cash.
Lower than 96% of companies in India.
Self-Funding Ratio
-1.3×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 89% of companies in India.
Cash Locked Ratio
₹40For every ₹100 of sales, ₹40 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹20 tied up three years earlier.
More money tied up than 76% of companies in India.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 64% of companies in India.
Growth Efficiency Ratio
₹4Sales grew 195% in 3 years; of every extra ₹100 of sales, ₹4 became extra profit.
Lower than 67% of companies in India.
Asset Productivity Ratio
+195% / +327%In 3 years sales changed by +195% while total assets changed by +327%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-0.0×Operating cash was negative last year, while some debt falls due within a year.
Lower than 77% of companies in India.
Cash Cushion Ratio
−81%Debt, after subtracting cash, equals 81% of its market value (net debt).
Lower than 91% of companies in India.
Tangible Assets Ratio
100%Of every ₹100 the company owns, ₹100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 60% of companies in India.
Tangible Net Worth Ratio
100%Of every ₹100 of net worth, ₹100 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 55% of companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
Sunrest Lifescience Limited owes ₹0.59 for every ₹1 it owns. Net profit rose 105% in the year to Mar 2026, and grew 26% a year on average over 3 years.
Compared with companies in India · latest annual results Mar 2026.
P/E ratio
7.7Investors pay ₹7.7 for every ₹1 of Sunrest Lifescience Limited's yearly profit, lower than 91% of companies in India.
P/B ratio
0.88The share price is 0.88 times Sunrest Lifescience Limited's book value per share, lower than 83% of companies in India.
Market cap
₹18 CrThe total market value of all of Sunrest Lifescience Limited's shares at today's price (share price × number of shares), smaller than 98% of companies in India. PosiCap size class: Nano Cap.
Net worth (book value)
₹20 CrWhat Sunrest Lifescience Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹39.60Net worth divided by the number of shares. The share price of ₹35.00 is 0.9 times this, which is the P/B above.
Owes vs Owns
0.59×Sunrest Lifescience Limited owes ₹0.59 for every ₹1 it owns (moderate), higher than 75% of companies in India.
Revenue growth
+112%Revenue rose 112% in the year to Mar 2026, and grew 43% a year on average over 3 years.
Profit growth
+105%Net profit rose 105% in the year to Mar 2026, and grew 26% a year on average over 3 years.
Profit margin
5.8%Sunrest Lifescience Limited keeps ₹6 of every ₹100 of revenue as net profit.
Cash quality
-0.0×Cash from Sunrest Lifescience Limited's business was -0.0× its reported profit in the year to Mar 2026 — the business used cash even though it reported a profit.
Interest cover
8.1×Sunrest Lifescience Limited's operating profit covered its interest costs 8.1 times in the year to Mar 2026.
Cash vs debt
Net debtSunrest Lifescience Limited had ₹15 Cr more debt than cash (net debt) at Mar 2026.
Questions
What is Sunrest Lifescience Limited's P/E ratio?
Investors pay ₹7.7 for every ₹1 of Sunrest Lifescience Limited's yearly profit, lower than 91% of companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Sunrest Lifescience Limited: ₹18 Cr ÷ ₹20 Cr (31 Mar 2026) = 0.9.
How much does Sunrest Lifescience Limited owe compared with what it owns?
Sunrest Lifescience Limited owes ₹0.59 for every ₹1 it owns (moderate), higher than 75% of companies in India.
Is Sunrest Lifescience Limited's revenue growing?
Revenue rose 112% in the year to Mar 2026, and grew 43% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.